| blood coagulation | GO:0007596 | 76 | 0.682 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.614 | |
| inflammatory response | GO:0006954 | 244 | 0.608 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.527 | |
| regulation of cell activation | GO:0050865 | 289 | 0.475 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.454 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.439 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.437 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.435 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.421 | |
| muscle tissue development | GO:0060537 | 308 | 0.418 | |
| hemostasis | GO:0007599 | 78 | 0.414 | |
| cerebral cortex development | GO:0021987 | 86 | 0.397 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.397 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.372 | |
| wound healing | GO:0042060 | 157 | 0.371 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.365 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.348 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.320 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.319 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.307 | |
| cation transport | GO:0006812 | 399 | 0.296 | |
| embryonic placenta development | GO:0001892 | 98 | 0.291 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.290 | |
| coagulation | GO:0050817 | 78 | 0.283 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.281 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.280 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.278 | |
| ossification | GO:0001503 | 216 | 0.250 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.245 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.239 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.239 | |
| unsaturated fatty acid biosynthetic process | GO:0006636 | 15 | 0.222 | |
| cytokine production | GO:0001816 | 319 | 0.219 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.214 | |
| muscle system process | GO:0003012 | 141 | 0.211 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.208 | |
| leukocyte migration | GO:0050900 | 124 | 0.204 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.200 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.198 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.194 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.193 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.184 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.183 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.183 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.178 | |
| cell chemotaxis | GO:0060326 | 81 | 0.176 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.176 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.172 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.169 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.164 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.161 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.159 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.159 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.158 | |
| forebrain development | GO:0030900 | 302 | 0.155 | |
| stem cell maintenance | GO:0019827 | 130 | 0.155 | |
| cell adhesion | GO:0007155 | 329 | 0.151 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.151 | |
| placenta development | GO:0001890 | 140 | 0.150 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.150 | |
| regulation of ossification | GO:0030278 | 112 | 0.150 | |
| anion transport | GO:0006820 | 177 | 0.148 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.146 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.145 | |
| action potential | GO:0001508 | 78 | 0.144 | |
| telencephalon development | GO:0021537 | 186 | 0.143 | |
| angiogenesis | GO:0001525 | 201 | 0.143 | |
| cation homeostasis | GO:0055080 | 212 | 0.142 | |
| chemotaxis | GO:0006935 | 247 | 0.141 | |
| t cell activation | GO:0042110 | 289 | 0.141 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.139 | |
| t cell proliferation | GO:0042098 | 120 | 0.139 | |
| killing by host of symbiont cells | GO:0051873 | 11 | 0.137 | |
| regulation of wound healing | GO:0061041 | 40 | 0.135 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.132 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.131 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.126 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.123 | |
| calcium ion transport | GO:0006816 | 159 | 0.122 | |
| humoral immune response | GO:0006959 | 57 | 0.120 | |
| b cell differentiation | GO:0030183 | 78 | 0.120 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.119 | |
| cellular magnesium ion homeostasis | GO:0010961 | 3 | 0.119 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.118 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.117 | |
| amine metabolic process | GO:0009308 | 45 | 0.115 | |
| granulocyte migration | GO:0097530 | 43 | 0.114 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.113 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.113 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.112 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.111 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.108 | |
| organelle assembly | GO:0070925 | 177 | 0.106 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.106 | |
| regulation of ion transport | GO:0043269 | 215 | 0.105 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.105 | |
| membrane organization | GO:0061024 | 245 | 0.105 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.104 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.104 | |
| ear development | GO:0043583 | 200 | 0.102 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.102 | |
| immune effector process | GO:0002252 | 321 | 0.102 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.101 | |
| skeletal system development | GO:0001501 | 356 | 0.100 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.100 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.099 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.099 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.099 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.097 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.096 | |
| amide transport | GO:0042886 | 138 | 0.096 | |
| clara cell differentiation | GO:0060486 | 4 | 0.096 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.095 | |
| platelet activation | GO:0030168 | 40 | 0.095 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.094 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.094 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.093 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.093 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.092 | |
| sensory perception | GO:0007600 | 245 | 0.092 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.092 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.090 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.090 | |
| regulation of muscle cell apoptotic process | GO:0010660 | 17 | 0.090 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.089 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.088 | |
| axonogenesis | GO:0007409 | 274 | 0.088 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.088 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.088 | |
| regulation of cell migration | GO:0030334 | 219 | 0.087 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.087 | |
| response to acid chemical | GO:0001101 | 111 | 0.087 | |
| salivary gland development | GO:0007431 | 37 | 0.087 | |
| heart contraction | GO:0060047 | 93 | 0.087 | |
| hematopoietic stem cell migration | GO:0035701 | 1 | 0.086 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.086 | |
| lipoxin a4 biosynthetic process | GO:2001303 | 1 | 0.086 | |
| striated muscle contraction | GO:0006941 | 45 | 0.085 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.085 | |
| developmental maturation | GO:0021700 | 193 | 0.084 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.083 | |
| compound eye development | GO:0048749 | 1 | 0.082 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.082 | |
| lung cell differentiation | GO:0060479 | 30 | 0.082 | |
| synaptic transmission | GO:0007268 | 329 | 0.081 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.081 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.081 | |
| ear morphogenesis | GO:0042471 | 118 | 0.080 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.080 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.079 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.079 | |
| muscle contraction | GO:0006936 | 101 | 0.079 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.079 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.078 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.078 | |
| regulation of defense response | GO:0031347 | 233 | 0.078 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.078 | |
| membrane depolarization | GO:0051899 | 64 | 0.078 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.077 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.077 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.076 | |
| lung secretory cell differentiation | GO:0061140 | 13 | 0.076 | |
| regulation of system process | GO:0044057 | 200 | 0.076 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.076 | |
| acute inflammatory response | GO:0002526 | 41 | 0.075 | |
| respiratory tube development | GO:0030323 | 167 | 0.075 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.074 | |
| biomineral tissue development | GO:0031214 | 64 | 0.073 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.073 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.073 | |
| regulation of cell motility | GO:2000145 | 236 | 0.072 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.072 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.071 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.071 | |
| fatty acid derivative biosynthetic process | GO:1901570 | 15 | 0.071 | |
| macrophage differentiation | GO:0030225 | 20 | 0.070 | |
| cellular homeostasis | GO:0019725 | 240 | 0.070 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.069 | |
| gliogenesis | GO:0042063 | 141 | 0.069 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.069 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.068 | |
| neutrophil migration | GO:1990266 | 37 | 0.068 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.067 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.066 | |
| cardiac chamber development | GO:0003205 | 108 | 0.066 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.066 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.065 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.064 | |
| neuron projection guidance | GO:0097485 | 141 | 0.064 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.064 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.063 | |
| icosanoid biosynthetic process | GO:0046456 | 15 | 0.063 | |
| heart morphogenesis | GO:0003007 | 178 | 0.063 | |
| septum primum development | GO:0003284 | 4 | 0.063 | |
| circulatory system process | GO:0003013 | 197 | 0.063 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.063 | |
| purinergic nucleotide receptor signaling pathway | GO:0035590 | 3 | 0.062 | |
| lung epithelium development | GO:0060428 | 37 | 0.062 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.062 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.062 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.061 | |
| transdifferentiation | GO:0060290 | 1 | 0.061 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.061 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.061 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 31 | 0.060 | |
| adaptive immune response | GO:0002250 | 155 | 0.060 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.059 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.059 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.059 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.059 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.059 | |
| cellular extravasation | GO:0045123 | 17 | 0.058 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.058 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.058 | |
| gland development | GO:0048732 | 330 | 0.058 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.058 | |
| mapk cascade | GO:0000165 | 281 | 0.058 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.057 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.057 | |
| microtubule based process | GO:0007017 | 236 | 0.057 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.057 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.057 | |
| lung development | GO:0030324 | 164 | 0.057 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.056 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.056 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.056 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.055 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.055 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.055 | |
| t cell migration | GO:0072678 | 19 | 0.055 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.055 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.055 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.054 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.054 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.054 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.054 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.053 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.053 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.053 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.053 | |
| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.052 | |
| transmembrane transport | GO:0055085 | 412 | 0.052 | |
| bone development | GO:0060348 | 120 | 0.052 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.052 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.052 | |
| defense response to nematode | GO:0002215 | 4 | 0.052 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.051 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.051 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.051 | |
| regulation of action potential | GO:0098900 | 4 | 0.051 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.051 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.051 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.051 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.051 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.051 | |
| detection of stimulus | GO:0051606 | 84 | 0.051 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.050 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.050 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.050 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.050 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.050 | |
| membrane invagination | GO:0010324 | 17 | 0.049 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.049 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.049 | |
| cell maturation | GO:0048469 | 127 | 0.049 | |
| cell growth | GO:0016049 | 130 | 0.049 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.049 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.049 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.049 | |
| neuron migration | GO:0001764 | 122 | 0.049 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.048 | |
| hindbrain development | GO:0030902 | 128 | 0.048 | |
| protein citrullination | GO:0018101 | 2 | 0.048 | |
| regulation of calcium mediated signaling | GO:0050848 | 19 | 0.048 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.047 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.046 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.046 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.046 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.046 | |
| tissue homeostasis | GO:0001894 | 115 | 0.046 | |
| metanephros development | GO:0001656 | 79 | 0.046 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.046 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.046 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.045 | |
| bone morphogenesis | GO:0060349 | 78 | 0.045 | |
| chromatin organization | GO:0006325 | 206 | 0.045 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.045 | |
| response to oxygen radical | GO:0000305 | 16 | 0.045 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.045 | |
| phosphatidylethanolamine biosynthetic process | GO:0006646 | 2 | 0.044 | |
| activation of mapk activity | GO:0000187 | 59 | 0.044 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.044 | |
| activation of immune response | GO:0002253 | 138 | 0.044 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.044 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.044 | |
| regulation of histone modification | GO:0031056 | 56 | 0.044 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.044 | |
| leukotriene production involved in inflammatory response | GO:0002540 | 2 | 0.044 | |
| epithelial cell development | GO:0002064 | 159 | 0.043 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.043 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.043 | |
| response to radiation | GO:0009314 | 165 | 0.043 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.043 | |
| muscle cell apoptotic process | GO:0010657 | 18 | 0.043 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.043 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.043 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.043 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.042 | |
| glial cell differentiation | GO:0010001 | 131 | 0.042 | |
| blood circulation | GO:0008015 | 195 | 0.042 | |
| bone mineralization | GO:0030282 | 54 | 0.042 | |
| heart process | GO:0003015 | 94 | 0.042 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.042 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.042 | |
| natural killer cell activation | GO:0030101 | 44 | 0.042 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.042 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.041 | |
| muscle cell development | GO:0055001 | 133 | 0.041 | |
| sclerotome development | GO:0061056 | 4 | 0.041 | |
| histone modification | GO:0016570 | 159 | 0.041 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.041 | |
| lymphocyte migration | GO:0072676 | 26 | 0.041 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.041 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.041 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.041 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.041 | |
| regulation of osteoblast proliferation | GO:0033688 | 15 | 0.041 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.041 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.040 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.039 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.039 | |
| kidney development | GO:0001822 | 213 | 0.039 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.039 | |
| protein secretion | GO:0009306 | 111 | 0.039 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.039 | |
| digestive system development | GO:0055123 | 200 | 0.039 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.039 | |
| osteoblast proliferation | GO:0033687 | 18 | 0.038 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.038 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.038 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.038 | |
| erythrocyte maturation | GO:0043249 | 6 | 0.037 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.037 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.037 | |
| phagocytosis | GO:0006909 | 66 | 0.037 | |
| regionalization | GO:0003002 | 337 | 0.037 | |
| tube formation | GO:0035148 | 140 | 0.037 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.037 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.037 | |
| regulation of secretion | GO:0051046 | 274 | 0.037 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.037 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.037 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.037 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.037 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.037 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.037 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.037 | |
| ammonium transmembrane transport | GO:0072488 | 2 | 0.037 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.037 | |
| chromatin modification | GO:0016568 | 187 | 0.037 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.037 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.037 | |
| defense response to virus | GO:0051607 | 68 | 0.036 | |
| pallium development | GO:0021543 | 120 | 0.036 | |
| organelle localization | GO:0051640 | 179 | 0.036 | |
| pancreas development | GO:0031016 | 57 | 0.036 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.036 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.036 | |
| respiratory system development | GO:0060541 | 190 | 0.036 | |
| response to growth factor | GO:0070848 | 198 | 0.036 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.036 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.036 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.036 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.036 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.035 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.035 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.035 | |
| substrate dependent cell migration cell extension | GO:0006930 | 4 | 0.035 | |
| regulation of neuron death | GO:1901214 | 134 | 0.035 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.035 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.035 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.035 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.035 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.035 | |
| regulation of stress fiber assembly | GO:0051492 | 15 | 0.034 | |
| citrulline biosynthetic process | GO:0019240 | 2 | 0.034 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.034 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.034 | |
| camera type eye development | GO:0043010 | 266 | 0.034 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.034 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.034 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.034 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.034 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.034 | |
| nephric duct formation | GO:0072179 | 4 | 0.034 | |
| multicellular organism growth | GO:0035264 | 161 | 0.034 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.034 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.034 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.034 | |
| cell junction organization | GO:0034330 | 77 | 0.034 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.033 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.033 | |
| connective tissue development | GO:0061448 | 179 | 0.033 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.033 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.033 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.033 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.033 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.033 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.033 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.033 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.033 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.033 | |
| myelination | GO:0042552 | 74 | 0.033 | |
| locomotory behavior | GO:0007626 | 195 | 0.033 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.033 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.033 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.032 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.032 | |
| negative regulation of t cell mediated immunity | GO:0002710 | 9 | 0.032 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.032 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.032 | |
| axon ensheathment | GO:0008366 | 76 | 0.032 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.032 | |
| leukocyte cell cell adhesion | GO:0007159 | 14 | 0.032 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.032 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.032 | |
| b cell activation | GO:0042113 | 161 | 0.031 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.031 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.031 | |
| camp metabolic process | GO:0046058 | 40 | 0.031 | |
| microglia differentiation | GO:0014004 | 2 | 0.031 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.031 | |
| appendage development | GO:0048736 | 166 | 0.031 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.031 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.031 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.030 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.030 | |
| lipoxygenase pathway | GO:0019372 | 5 | 0.030 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.030 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.030 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.030 | |
| proepicardium development | GO:0003342 | 2 | 0.030 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.030 | |
| response to oxidative stress | GO:0006979 | 123 | 0.030 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.030 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.030 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.030 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.030 | |
| regulation of actin filament bundle assembly | GO:0032231 | 18 | 0.030 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.030 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.030 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.030 | |
| positive regulation of calcium mediated signaling | GO:0050850 | 15 | 0.029 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.029 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.029 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.029 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.029 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.029 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.029 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.029 | |
| regulation of oligodendrocyte differentiation | GO:0048713 | 23 | 0.029 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.029 | |
| myofibril assembly | GO:0030239 | 34 | 0.029 | |
| endomembrane system organization | GO:0010256 | 147 | 0.029 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.029 | |
| maintenance of location | GO:0051235 | 89 | 0.029 | |
| fat cell differentiation | GO:0045444 | 160 | 0.029 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.029 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.029 | |
| endocrine system development | GO:0035270 | 98 | 0.029 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.029 | |
| regulation of eosinophil degranulation | GO:0043309 | 1 | 0.028 | |
| striated muscle cell development | GO:0055002 | 125 | 0.028 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.028 | |
| protein catabolic process | GO:0030163 | 221 | 0.028 | |
| eosinophil migration | GO:0072677 | 3 | 0.028 | |
| response to retinoic acid | GO:0032526 | 56 | 0.028 | |
| fucosylation | GO:0036065 | 9 | 0.028 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.028 | |
| detection of external stimulus | GO:0009581 | 61 | 0.028 | |
| lung alveolus development | GO:0048286 | 45 | 0.028 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.028 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.028 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.028 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.028 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.027 | |
